An evaluation of the potential to use tumor-associated antigens as targets for antitumor T cell therapy using transgenic mice expressing a retroviral tumor antigen in normal lymphoid tissues.
J Exp Med (1993) 177 (6): 1681–1690.
Currently there are no citedby results. Try again later.
